Table: Fuso Pharmaceutical - 6-MTH parent results

Fuso Pharmaceutical Industries

11/11/2024 04:40

Nov 11 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2024        Sep 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             29.74               27.42            60.00    
                 (+8.4 pct)          (+8.1 pct)       (+8.3 pct)  
  Operating          2.43                1.10             4.00    
                (+121.4 pct)         (-14.4 pct)     (+103.7 pct) 
  Recurring          2.14                1.10             3.70    
                 (+95.2 pct)         (-21.5 pct)      (+98.1 pct) 
  Net                1.54              717 mln            2.60    
                (+114.2 pct)         (-29.6 pct)      (+88.7 pct) 
  EPS            179.75 yen           82.18 yen       304.32 yen  
  Ann Div                             70.00 yen        82.00 yen  
  -Q2 div         40.00 yen           35.00 yen                   
  -Q4 div                             35.00 yen        42.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T